Stratton Management’s GSK GSK Stock Holding History

Stratton Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$703K	Sell	13,939 -6,315	-31%	-$322K	0.09%	162
2015 Q3	$973K	Buy	20,254 +8,630	+74%	+$449K	0.11%	149
2015 Q2	$605K	Sell	11,624 -840	-7%	-$47.3K	0.03%	267
2015 Q1	$719K	Sell	12,464 -120	-1%	-$6.88K	0.03%	275
2014 Q4	$672K	Buy	12,584 +1,300	+12%	+$72.7K	0.03%	273
2014 Q3	$648K	Sell	11,284 -1,280	-10%	-$78.5K	0.03%	267
2014 Q2	$840K	Sell	12,564 -264	-2%	-$17.9K	0.03%	266
2014 Q1	$857K	Buy	12,828 +120	+0.9%	+$8.11K	0.04%	256
2013 Q4	$848K	Sell	12,708 -40	-0.3%	-$2.59K	0.04%	263
2013 Q3	$799K	Buy	12,748 +2,064	+19%	+$133K	0.04%	264
2013 Q2	$667K	Buy	+10,684	New	+$678K	0.04%	259

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stratton Management's GSK Position: Q4 2015 in Review

Stratton Management reduced its GSK (GSK) stake by 31% in Q4 2015, selling an estimated $322K and leaving 13,939 shares worth $703K. The position accounts for 0.09% of the portfolio, ranked #162.

Stratton Management first reported a position in GSK in Q2 2013 and has held it in 11 quarters since. The position peaked at $973K in Q3 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Stratton Management held 13,939 shares of GSK worth $703K as of Q4 2015.
Stratton Management sold 6,315 GSK shares in Q4 2015, an estimated $322K.
GSK made up 0.09% of Stratton Management's portfolio in Q4 2015, its #162 holding.
Stratton Management first reported a position in GSK in Q2 2013 and has held it in 11 quarters since.
Stratton Management's GSK position peaked at $973K in Q3 2015.
719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.